Literature DB >> 11583945

Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.

S Weisberg1, E Ashkenazi, Z Israel, M Attia, Y Shoshan, F Umansky, C Brodie.   

Abstract

In this study we characterized the expression of Fas and Fas ligand in different types of meningiomas and examined the effect of Fas ligation on the death of meningioma cells in culture. Using Western blot analysis, we found that extracts derived from anaplastic and atypical meningiomas expressed high levels of Fas, whereas benign meningiomas did not express detectable levels of this protein. All of the meningiomas examined expressed low levels of Fas ligand. Cultures of anaplastic meningiomas also expressed Fas and treatment of these cells with anti-Fas antibody induced cell death. The results of this study indicate that Fas is preferentially expressed in atypical and anaplastic meningiomas and suggest that it is involved in the increased apoptosis observed in these tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583945      PMCID: PMC1850505          DOI: 10.1016/S0002-9440(10)62504-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

Review 1.  Structure and function of Fas/Fas ligand.

Authors:  J R Orlinick; A K Vaishnaw; K B Elkon
Journal:  Int Rev Immunol       Date:  1999       Impact factor: 5.311

2.  FLIP is constitutively hyperexpressed in Fas-resistant U266 myeloma cells, but is not induced by IL-6 in Fas-sensitive RPM18226 cells.

Authors:  D K Kim; E S Cho; J H Yoo; H D Um
Journal:  Mol Cells       Date:  2000-10-31       Impact factor: 5.034

3.  Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.

Authors:  C M Mueller; D W Scott
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 4.  The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.

Authors:  H Walczak; P H Krammer
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

5.  A comparative study of Fas and Fas-ligand expression during melanoma progression.

Authors:  C Soubrane; R Mouawad; E C Antoine; O Verola; M Gil-Delgado; D Khayat
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

Review 6.  Death receptors in cutaneous biology and disease.

Authors:  P Wehrli; I Viard; R Bullani; J Tschopp; L E French
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

7.  The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes.

Authors:  K C Wollert; J Heineke; J Westermann; M Lüdde; B Fiedler; W Zierhut; D Laurent; M K Bauer; K Schulze-Osthoff; H Drexler
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

8.  Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome.

Authors:  C M Abramovich; R A Prayson
Journal:  Am J Clin Pathol       Date:  2000-07       Impact factor: 2.493

9.  Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma.

Authors:  F Basolo; L Fiore; A Baldanzi; R Giannini; M Dell'Omodarme; G Fontanini; F Pacini; R Danesi; P Miccoli; A Toniolo
Journal:  Lab Invest       Date:  2000-09       Impact factor: 5.662

10.  Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.

Authors:  M Jenkins; M Keir; J M McCune
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

View more
  1 in total

Review 1.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.